Abbott Ireland Financing DAC, established in Dublin as a subsidiary of Abbott Laboratories, focuses on financing operations within the healthcare sector. The company plays a critical role in managing capital resources, facilitating Abbott's investments in innovative healthcare solutions worldwide.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| ABT 0.38% 2027-11-19 EURAbbott Ireland Financing DAC | Ireland | 2027-11-19 | 0.375 | 2.35 |
| ABT 1.50% 2026-09-27 EURAbbott Ireland Financing DAC | Ireland | 2026-09-27 | 1.500 | 2.15 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Since its inception, Abbott Ireland Financing DAC has been active in the bond market, with significant issuances dating back to 2014. Noteworthy transactions include a €1 billion bond issuance in 2021, aimed at refinancing existing debt, which was well-received in the market, reflecting strong investor confidence. Current yields on their bonds are competitive, often outperforming industry averages, bolstered by robust financial performance and strategic growth initiatives.